The platform is exploring how a clinical team might understand and govern a complex rare-cancer patient’s state across time, evidence, decisions, and institutions.
You do not need to learn special terminology before you begin. Feedback can be opened at any time and remains only in this browser unless you choose to copy, print, or download it.